Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
暂无分享,去创建一个
Sabrina Oliveira | H. S. de Bruijn | Dominic J. Robinson | S. Oliveira | D. Robinson | V. Mashayekhi | Demian van Straten | Vida Mashayekhi | Henriette S. de Bruijn | Demian van Straten | Vida Mashayekhi | Demian van Straten
[1] Michael R Hamblin,et al. On the mechanism of the tumour-localising effect in photodynamic therapy. , 1994, Journal of photochemistry and photobiology. B, Biology.
[2] R. Boyle,et al. Structure and Biodistribution Relationships of Photodynamic Sensitizers * , 1996, Photochemistry and photobiology.
[3] Zheng Huang,et al. Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges , 2008, Technology in cancer research & treatment.
[4] Martyna Elas,et al. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy. , 2014, Free radical biology & medicine.
[5] M. Kuimova,et al. Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosesitizer conjugates suitable for photodynamic therapy , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[6] J. Piette,et al. NF-κB in Photodynamic Therapy: Discrepancies of a Master Regulator , 2006 .
[7] H. S. de Bruijn,et al. Somatostatin Analogues for Receptor Targeted Photodynamic Therapy , 2014, PloS one.
[8] A. Zinsmeister,et al. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. , 2008, Gastroenterology.
[9] M. Hefti,et al. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro , 2014, Neurological research.
[10] N. Al-Waili,et al. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[11] S. Gollnick,et al. Enhancement of anti-tumor immunity by photodynamic therapy , 2010, Immunologic research.
[12] I. Tan,et al. A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer , 2012, European Archives of Oto-Rhino-Laryngology.
[13] R. Pandey,et al. TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT. , 2011, ACS medicinal chemistry letters.
[14] Chih-Ching Wu,et al. Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets , 2003, Journal of cellular physiology.
[15] B. Kruijt,et al. Laser speckle imaging of dynamic changes in flow during photodynamic therapy , 2006, Lasers in Medical Science.
[16] A. Bugaj. Targeted photodynamic therapy — a promising strategy of tumor treatment , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[17] A. Sieroń,et al. Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-A review. , 2015, Photodiagnosis and photodynamic therapy.
[18] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[19] N. J. Brown,et al. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. , 1998, British Journal of Cancer.
[20] A. Kaye,et al. SUBCELLULAR LOCALIZATION OF PORPHYRINS USING CONFOCAL LASER SCANNING MICROSCOPY , 1991, Photochemistry and photobiology.
[21] E. Akkaya,et al. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light. , 2016, Angewandte Chemie.
[22] P. Agostinis,et al. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity , 2010, Apoptosis.
[23] P. Brun,et al. Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer. , 2015, European journal of medicinal chemistry.
[24] P. Steijlen,et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. , 2013, The Lancet. Oncology.
[25] Nancy L Oleinick,et al. EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[26] S. Dhar,et al. Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[27] R. Pandey,et al. Polyacrylamide-Based Biocompatible Nanoplatform Enhances the Tumor Uptake, PET/fluorescence Imaging and Anticancer Activity of a Chlorophyll Analog , 2014, Theranostics.
[28] Herbert Stepp,et al. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate , 2008, Lasers in surgery and medicine.
[29] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[30] Wenjun Guo,et al. Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.
[31] David Goldstein,et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.
[32] C. Mosse,et al. Photodynamic therapy outcome for oral dysplasia , 2011, Lasers in surgery and medicine.
[33] T. Pawlik,et al. Multidisciplinary management and the future of treatment in cholangiocarcinoma , 2016 .
[34] B. Wilson,et al. Magnetic resonance imaging correlated with the histopathological effect of Pd‐bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland , 2006, Lasers in surgery and medicine.
[35] Michael R Hamblin,et al. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer , 2014, Journal of biophotonics.
[36] H. Stepp,et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy , 2005, BJU international.
[37] Theresa M Busch,et al. Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.
[38] M. V. Scott,et al. Pilot Study on Light Dosimetry Variables for Photodynamic Therapy of Barrett's Esophagus with High-Grade Dysplasia , 2009, Clinical Cancer Research.
[39] H. Rotsztejn,et al. Light-emitting diodes in photodynamic therapy in non-melanoma skin cancers – own observations and literature review , 2016, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.
[40] Anirban Sen Gupta,et al. A cell-targeted photodynamic nanomedicine strategy for head and neck cancers. , 2013, Molecular pharmaceutics.
[41] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[42] H. Dvorak,et al. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.
[43] Li Junliang,et al. Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine , 2011, Medical oncology.
[44] Nancy L Oleinick,et al. The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[45] Huixin He,et al. Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy , 2015, International journal of nanomedicine.
[46] Siyu Chen,et al. Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy , 2016, International journal of biological sciences.
[47] Masataka Uehara,et al. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia. , 2013, Photodiagnosis and photodynamic therapy.
[48] K. Moghissi. PDT: The plight. , 2007, Photodiagnosis and photodynamic therapy.
[49] J. Neoptolemos,et al. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study , 1995, The British journal of surgery.
[50] Chen-Yuan Dong,et al. Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED). , 2015, Photodiagnosis and photodynamic therapy.
[51] P. Hillemanns,et al. Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium , 2010, Lasers in surgery and medicine.
[52] Tayyaba Hasan,et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.
[53] N. Normanno,et al. EGFR-targeted therapy. , 2011, Experimental cell research.
[54] Malini Olivo,et al. Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. , 2007, The Lancet. Oncology.
[55] F. Moloney,et al. Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.
[56] R. Geronemus,et al. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study. , 2008, Journal of the American Academy of Dermatology.
[57] Tayyaba Hasan,et al. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. , 2005, International journal of radiation oncology, biology, physics.
[58] Christian Dannecker,et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. , 2006, Gynecologic oncology.
[59] P. Hillemanns,et al. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2. , 2015, American journal of obstetrics and gynecology.
[60] E. Panzarini,et al. Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy , 2012, Cells.
[61] M. Sam Eljamel,et al. ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.
[62] N. Oleinick,et al. The Death of Human Cancer Cells Following Photodynamic Therapy: Apoptosis Competence is Necessary for Bcl‐2 Protection but not for Induction of Autophagy † , 2007, Photochemistry and photobiology.
[63] H. S. de Bruijn,et al. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. , 2013, Photodiagnosis and photodynamic therapy.
[64] Jarod C Finlay,et al. Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy , 2015, Photochemistry and photobiology.
[65] Sabrina Oliveira,et al. Nanobody-photosensitizer conjugates for targeted photodynamic therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[66] T. Dougherty,et al. Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of 3-(1'-alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicity. , 2001, Journal of medicinal chemistry.
[67] T. Hasan,et al. PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) * , 1994, Photochemistry and photobiology.
[68] A. Jemal,et al. Global Cancer Statistics , 2011 .
[69] Mark A. Weston,et al. Validation and Application of a Model of Oxygen Consumption and Diffusion During Photodynamic Therapy In Vitro , 2014, Photochemistry and photobiology.
[70] Timothy Zhu,et al. A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis , 2006, Clinical Cancer Research.
[71] A. Evans,et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. , 2007, The Journal of urology.
[72] Xiaoxiao Zhang,et al. Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy. , 2015, Organic & biomolecular chemistry.
[73] Yueqing Gu,et al. Real-Time Monitoring of Singlet Oxygen and Oxygen Partial Pressure During the Deep Photodynamic Therapy In Vitro , 2016, Annals of Biomedical Engineering.
[74] Ken Kang-Hsin Wang,et al. A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.
[75] Frederic Leblond,et al. Quantitative spatial frequency fluorescence imaging in the sub-diffusive domain for image-guided glioma resection. , 2015, Biomedical optics express.
[76] H. Maeda,et al. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.
[77] Avigdor Scherz,et al. WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model¶ , 2005, Photochemistry and Photobiology.
[78] Brian C Wilson,et al. Photodynamic therapy of brain tumors—A work in progress , 2006, Lasers in surgery and medicine.
[79] M. Berns,et al. TUMOR DESTRUCTION IN PHOTODYNAMIC THERAPY , 1987, Photochemistry and photobiology.
[80] A. Akopov,et al. Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. , 2014, Photodiagnosis and photodynamic therapy.
[81] B W Henderson,et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.
[82] P. Vaupel,et al. Treatment resistance of solid tumors: role of hypoxia and anemia. , 2001, Medical oncology.
[83] Adrian Mariampillai,et al. Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment. , 2008, Journal of biomedical optics.
[84] Hiroshi Iseki,et al. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. , 2013, Journal of neurosurgery.
[85] Martin G. Mack,et al. Interstitial photodynamic laser therapy in interventional oncology , 2004, European Radiology.
[86] Timothy C Zhu,et al. Characterization of tissue optical properties for prostate PDT using interstitial diffuse optical tomography , 2012, BiOS.
[87] Mladen Korbelik,et al. Photodynamic therapy-generated vaccine for cancer therapy , 2006, Cancer Immunology, Immunotherapy.
[88] F. Bolze,et al. A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection. , 2016, Chemistry.
[89] J. Usuda,et al. Outcome of Photodynamic Therapy Using NPe6 for Bronchogenic Carcinomas in Central Airways >1.0 cm in Diameter , 2010, Clinical Cancer Research.
[90] Michael R Hamblin,et al. Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A. , 2013, Cancer research.
[91] T. Hirata,et al. Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital , 2006, Lasers in surgery and medicine.
[92] Clare Allen,et al. TOOKAD® Soluble vascular‐targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer , 2013, BJU international.
[93] P. Speight,et al. Photodynamic therapy using mTHPC for malignant disease in the oral cavity , 1997, International journal of cancer.
[94] C. Hopper,et al. Photodynamic therapy: a clinical reality in the treatment of cancer. , 2000, The Lancet. Oncology.
[95] Michael R Hamblin,et al. Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. , 2014, World journal of immunology.
[96] B. Henderson,et al. A Phase I Study of Light Dose for Photodynamic Therapy Using 2‐[1‐Hexyloxyethyl]‐2 Devinyl Pyropheophorbide‐a for the Treatment of Non–Small Cell Carcinoma In Situ or Non–Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[97] Barbara W Henderson,et al. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. , 2007, Cancer research.
[98] Michael R Hamblin,et al. Cell Death Pathways in Photodynamic Therapy of Cancer , 2011, Cancers.
[99] Barbara W Henderson,et al. Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.
[100] Mladen Korbelik,et al. Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines , 2015, International journal of molecular sciences.
[101] P. Lai,et al. Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model. , 2012, Small.
[102] C. Hopper,et al. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. , 2001, International journal of oral and maxillofacial surgery.
[103] S. J. Kim,et al. Photodynamic therapy for premalignant lesions of the vulva and vagina: A long‐term follow‐up study , 2015, Lasers in surgery and medicine.
[104] Michael R Hamblin,et al. Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response , 2010, PloS one.
[105] C. Berking,et al. Photodynamic therapy with BF‐200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer‐blind phase III study in comparison with a registered methyl‐5‐aminolaevulinate cream and placebo , 2012, The British journal of dermatology.
[106] Sandra Nuyts,et al. Postoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue , 2015, World Journal of Surgical Oncology.
[107] 亀山 哲章,et al. Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles : a proof of concept study , 2012 .
[108] M Emberton,et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer , 2006, Lasers in surgery and medicine.
[109] A. Balestrazzi,et al. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. , 2010, Ophthalmology.
[110] N. Bhardwaj,et al. Dendritic cells resurrect antigens from dead cells. , 2001, Trends in immunology.
[111] B. Pogue,et al. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer , 2016, British Journal of Cancer.
[112] Patrizia Agostinis,et al. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.
[113] Hedy E. Larkin,et al. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. , 1993, Cancer research.
[114] S R Arridge,et al. Recent advances in diffuse optical imaging , 2005, Physics in medicine and biology.
[115] M. Baptista,et al. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers , 2009, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[116] D. Kessel,et al. ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage , 2012, Autophagy.
[117] C. Shields,et al. Photodynamic therapy for choroidal metastasis in 8 cases. , 2012, Ophthalmology.
[118] R. Boyle,et al. Development of PDT/PET Theranostics: Synthesis and Biological Evaluation of an (18)F-Radiolabeled Water-Soluble Porphyrin. , 2015, Molecular pharmaceutics.
[119] Napoleone Ferrara,et al. Antiangiogenic Therapy for Cancer: An Update , 2007, Cancer journal.
[120] S. Dhar,et al. Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells. , 2015, Methods in molecular biology.
[121] A. Villers,et al. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model. , 2013, Photodiagnosis and photodynamic therapy.
[122] Tetsuya Nakamura,et al. Usefulness of Photodynamic Diagnosis and Therapy using Talaporfin Sodium for an Advanced-aged Patient with Inoperable Gastric Cancer (a secondary publication). , 2014, Laser therapy.
[123] T. Wieman,et al. The Effects of Thrombocytopenia on Vessel Stasis and Macromolecular Leakage after Photodynamic Therapy Using Photofrin , 1997, Photochemistry and photobiology.
[124] Zheng Huang,et al. Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.
[125] T. Whiteside,et al. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. , 2000, Cancer research.
[126] Wei R. Chen,et al. Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma , 2015, Oncotarget.
[127] Li-bo Li,et al. Photodynamic therapy for intractable bronchial lung cancer. , 2013, Photodiagnosis and photodynamic therapy.
[128] J. Celli. Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy? , 2012, Israel journal of chemistry.
[129] D. Kessel,et al. Initiation of autophagy by photodynamic therapy. , 2009, Methods in enzymology.
[130] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[131] I Rosenthal,et al. Release of clotting factors from photosensitized endothelial cells: A possible trigger for blood vessel occlusion by photodynamic therapy , 1988, FEBS letters.
[132] J. Luketich,et al. Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer , 2007, Annals of Surgical Oncology.
[133] A. M. Olsen,et al. The use of a derivative of hematoporphyrin in tumor detection. , 1961 .
[134] Hisataka Kobayashi,et al. Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.
[135] Jang-Ming Lee,et al. Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread , 2015, PloS one.
[136] P. Kienle,et al. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. , 2013, The Cochrane database of systematic reviews.
[137] B. Wilson,et al. In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications , 1998, Photochemistry and photobiology.
[138] A. Beg,et al. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. , 2002, Trends in immunology.
[139] W. Jerjes,et al. Photodynamic therapy: The minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma , 2011, Lasers in surgery and medicine.
[140] Michael R Hamblin,et al. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy. , 2014, European journal of cancer.
[141] Keith Cengel,et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. , 2012, The Annals of thoracic surgery.
[142] Myung-Hwan Kim,et al. Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma. , 2014, European journal of cancer.
[143] Anirban Sen Gupta,et al. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[144] J. Feyh. Photodynamic treatment for cancers of the head and neck. , 1996, Journal of photochemistry and photobiology. B, Biology.
[145] Andreas Obermeier,et al. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX , 2007, Lasers in surgery and medicine.
[146] H. Kato,et al. Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy. , 2005, Chest.
[147] J. Usuda,et al. Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[148] Herbert Stepp,et al. Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia. , 2008, American journal of obstetrics and gynecology.
[149] U Anegg,et al. Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer—A clinical pilot study , 2001, Lasers in surgery and medicine.
[150] H. S. de Bruijn,et al. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin , 2016, PloS one.
[151] Peter Hillemanns,et al. Topical hexaminolevulinate photodynamic therapy for the treatment of persistent human papilloma virus infections and cervical intraepithelial neoplasia , 2015, Expert opinion on investigational drugs.
[152] C. Foote. DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATION , 1991, Photochemistry and photobiology.
[153] Myung-Hwan Kim,et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter , 2015, Endoscopy.
[154] W. Mali,et al. Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody , 2012, Molecular imaging.
[155] Wei Zhang,et al. Calreticulin as Cancer Treatment Adjuvant: Combination with Photodynamic Therapy and Photodynamic Therapy-Generated Vaccines , 2015, Front. Oncol..
[156] L J Schouten,et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.
[157] Ludmil Benov,et al. Photodynamic Therapy: Current Status and Future Directions , 2014, Medical Principles and Practice.
[158] P. Hillemanns,et al. Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low‐grade cervical intraepithelial neoplasia , 2014, Lasers in surgery and medicine.
[159] R. Scheff,et al. Non–Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers , 2013, Seminars in Interventional Radiology.
[160] D. Kessel,et al. Apoptosis and Autophagy After Mitochondrial or Endoplasmic Reticulum Photodamage † , 2007, Photochemistry and photobiology.
[161] N. Nishioka,et al. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. , 2009, Gastrointestinal endoscopy.
[162] A. Hofstetter,et al. Photodynamic selectivity of 5-aminolevulinic acid to prostate cancer cells. , 2006, Journal of the Egyptian National Cancer Institute.
[163] G. Duthie,et al. Can photodynamic therapy be the preferred treatment option for anal intraepithelial neoplasia? Initial results of a pilot study. , 2014, Photodiagnosis and Photodynamic Therapy.
[164] A. Zinsmeister,et al. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus , 2008, Cancer.
[165] Michael J. Emanuele,et al. Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.
[166] T. Maisch,et al. Fluorescence induction of protoporphyrin IX by a new 5‐aminolevulinic acid nanoemulsion used for photodynamic therapy in a full‐thickness ex vivo skin model , 2009, Experimental dermatology.
[167] Ulas Sunar,et al. Photodynamic Therapy with 3-(1′-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity , 2013, Clinical Cancer Research.
[168] S. Yoshida,et al. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. , 2005, Gastrointestinal endoscopy.
[169] W. Jerjes,et al. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma , 2011, Lasers in surgery and medicine.
[170] T. Patel. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.
[171] J. Gray,et al. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus. , 2013, Photodiagnosis and photodynamic therapy.
[172] B. Henderson,et al. BIODISTRIBUTION AND PDT EFFICACY OF A KETOCHLORIN PHOTOSENSITIZER AS A FUNCTION OF THE DELIVERY VEHICLE , 1994, Photochemistry and photobiology.
[173] Michael R Hamblin,et al. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. , 2013, Bioanalysis.
[174] S. Nakajima,et al. Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX‐S10(Na) , 2003, Lasers in surgery and medicine.
[175] A. Evans,et al. Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses , 2008, BJU international.
[176] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.
[177] Allen Cm,et al. Role of activated oxygen species in photodynamic therapy. , 2000 .
[178] A. Enk,et al. Photodynamic therapy – Aspects of pain management , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[179] C. Mosse,et al. Ultrasound‐guided photodynamic therapy for deep seated pathologies: prospective study , 2009, Lasers in surgery and medicine.
[180] C. Denlinger,et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma , 2016, Cancer.
[181] C M Allen,et al. Role of activated oxygen species in photodynamic therapy. , 2000, Methods in enzymology.
[182] Jie-Young Song,et al. Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors. , 2012, Cancer letters.
[183] James B. Mitchell,et al. Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates. , 2015, Free radical biology & medicine.
[184] H. S. de Bruijn,et al. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.
[185] J Moan,et al. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.
[186] W. Merlevede,et al. Photocytotoxicity of hypericin in normoxic and hypoxic conditions. , 2000, Journal of photochemistry and photobiology. B, Biology.
[187] Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response , 2011 .
[188] S. Gollnick,et al. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells , 2007, British Journal of Cancer.
[189] Fei He,et al. A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light. , 2015, ACS nano.
[190] C. Sibata,et al. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). , 2010, Photodiagnosis and photodynamic therapy.
[191] D. Oh,et al. Mitochondria and DNA Targeting of 5,10,15,20-Tetrakis(7-sulfonatobenzo[b]thiophene) Porphyrin-Induced Photodynamic Therapy via Intrinsic and Extrinsic Apoptotic Cell Death. , 2015, Journal of medicinal chemistry.
[192] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[193] Daniel J Klionsky,et al. Development by self-digestion: molecular mechanisms and biological functions of autophagy. , 2004, Developmental cell.
[194] F. Berr,et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.
[195] K Dane Wittrup,et al. Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. , 2008, Advanced drug delivery reviews.
[196] R. D. Barabash,et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. , 1991, Archives of surgery.
[197] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[198] T. Hasan,et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.
[199] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[200] W. Gallagher,et al. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.
[201] F. Guillemin,et al. Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future , 2015, Lasers in Medical Science.
[202] T. Foster,et al. Photosensitized release of von Willebrand factor from cultured human endothelial cells. , 1991, Cancer research.
[203] J Alfred Witjes,et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.
[204] T. Delaney,et al. Photodynamic therapy of cancer. , 1988, Comprehensive therapy.
[205] K. Chester,et al. Targeted photodynamic therapy with multiply‐loaded recombinant antibody fragments , 2007, International journal of cancer.
[206] J. Garcia-Arumi,et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. , 2009, Ophthalmology.
[207] H. C. de Vijlder,et al. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. , 2012, Acta dermato-venereologica.
[208] Tayyaba Hasan,et al. Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT , 2011, PloS one.
[209] Christian Dannecker,et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy , 2006 .
[210] H. Zimmermann,et al. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. , 1997, Journal of photochemistry and photobiology. B, Biology.
[211] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.
[212] Dong Ha Kim,et al. Near-infrared light-responsive nanomaterials for cancer theranostics. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[213] Jarod C Finlay,et al. Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light , 2006, Photochemistry and photobiology.
[214] P. Choyke,et al. Improving the Efficacy of Photoimmunotherapy (PIT) using a Cocktail of Antibody Conjugates in a Multiple Antigen Tumor Model , 2013, Theranostics.
[215] Peter Hillemanns,et al. Photodynamic therapy of cervical intraepithelial neoplasia 1–3 and human papilloma virus (HPV) infection with methylaminolevulinate and hexaminolevulinate—A double‐blind, dose‐finding study , 2012, Lasers in surgery and medicine.
[216] Cédric Cochrane,et al. Light emitting fabric technologies for photodynamic therapy. , 2015, Photodiagnosis and photodynamic therapy.
[217] N. Oku,et al. Photodynamic therapy targeted to tumor-induced angiogenic vessels. , 2001, Cancer letters.
[218] Robert J. Lee,et al. Targeted drug delivery via folate receptors. , 2008, Expert opinion on drug delivery.
[219] F. Guillemin,et al. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies. , 2008, Journal of medicinal chemistry.
[220] Michael R Hamblin,et al. Drug Carrier for Photodynamic Cancer Therapy , 2015, International journal of molecular sciences.
[221] G. Kenyon,et al. Treatment of head and neck cancer with photodynamic therapy: results after one year , 1995, The Journal of Laryngology & Otology.
[222] M. Landthaler,et al. Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo , 2003, British Journal of Cancer.
[223] S. Yoshida,et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. , 2008, Endoscopy.
[224] W. Campbell,et al. Treatment of amelanotic choroidal melanoma with photodynamic therapy. , 2012, Retina.
[225] D. Robinson,et al. Photodynamic therapy with systemic meta‐tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3 , 2012, Lasers in surgery and medicine.
[226] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[227] Jiro Akimoto,et al. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. , 2012, Photodiagnosis and photodynamic therapy.
[228] Thomas H Foster,et al. Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.
[229] Il Yoon,et al. Advance in Photosensitizers and Light Delivery for Photodynamic Therapy , 2013, Clinical endoscopy.
[230] Xiaoyuan Chen,et al. Dual imaging-guided photothermal/photodynamic therapy using micelles. , 2014, Biomaterials.
[231] Jarod C Finlay,et al. In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy , 2004, SPIE BiOS.
[232] C. Mosse,et al. Optimal conditions for successful ablation of high-grade dysplasia in Barrett’s oesophagus using aminolaevulinic acid photodynamic therapy , 2009, Lasers in Medical Science.
[233] T. Hasan,et al. Mechanisms of resistance to photodynamic therapy. , 2011, Current medicinal chemistry.
[234] C. Hoy,et al. Correction for tissue optical properties enables quantitative skin fluorescence measurements using multi-diameter single fiber reflectance spectroscopy. , 2015, Journal of dermatological science.
[235] J. Fuchs,et al. The role of oxygen in cutaneous photodynamic therapy. , 1998, Free radical biology & medicine.
[236] I. Tan,et al. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. , 2003, Archives of otolaryngology--head & neck surgery.
[237] Michael R Hamblin,et al. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model , 2008, Proceedings of the National Academy of Sciences.
[238] B. Steinberg,et al. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. , 2005, Archives of otolaryngology--head & neck surgery.
[239] Ying-xin Li,et al. Generation of effective vaccines against liver cancer by using photodynamic therapy , 2009, Lasers in Medical Science.
[240] Hector Nava,et al. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. , 2003, Cancer research.
[241] Michael R Hamblin,et al. Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.
[242] F. Hetzel,et al. Tumor Oxygenation Changes Post‐Photodynamic Therapy , 1996, Photochemistry and photobiology.
[243] W. Chow,et al. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005 , 2009, British Journal of Cancer.
[244] Simon R. Cherry,et al. A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin , 2014, Nature Communications.
[245] H. Kostron,et al. Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors , 2006 .
[246] V. Gebski,et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.
[247] K. Kaneko,et al. Photodynamic Therapy for Esophageal cancer , 1990 .
[248] S. V. Shliakhtsin,et al. Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon. , 2010, Photodiagnosis and photodynamic therapy.
[249] W. Ji,et al. The effect of Radachlorin® PDT in advanced NSCLC: a pilot study. , 2013, Photodiagnosis and photodynamic therapy.
[250] J. Krosl,et al. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.
[251] D. Doiron,et al. Photodynamic Therapy for Nonmelanoma Skin Cancer , 1989, Facial plastic surgery : FPS.
[252] G Corbitt,et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. , 2001, Cancer research.
[253] Tayyaba Hasan,et al. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[254] Victor M Montori,et al. Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses. , 2012, Photodiagnosis and photodynamic therapy.
[255] G. Dolivet,et al. Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study , 2010, Head & neck.
[256] Y. Choi,et al. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy. , 2013, The Journal of urology.
[257] F. Hetzel,et al. Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.
[258] C. Shim,et al. Role of Photodynamic Therapy in the Palliation of Obstructing Esophageal Cancer , 2012, The Korean journal of internal medicine.
[259] M. Korbelik,et al. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. , 2002, Cancer letters.
[260] R. Boyle,et al. Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer , 2007, Immunology.
[261] I. Batinic-Haberle,et al. Effect of Molecular Characteristics on Cellular Uptake, Subcellular Localization, and Phototoxicity of Zn(II) N-Alkylpyridylporphyrins* , 2013, The Journal of Biological Chemistry.
[262] Stefan Andersson-Engels,et al. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer. , 2010, Journal of biomedical optics.
[263] E. Otsuji,et al. 5-Aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes of different wavelengths in a mouse model of peritoneally disseminated gastric cancer. , 2013, The Journal of surgical research.
[264] M. Wang,et al. Multifunctional Nano-Bioprobes Based on Rattle-Structured Upconverting Luminescent Nanoparticles. , 2015, Angewandte Chemie.
[265] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[266] Harold S. Freeman,et al. Dye Sensitizers for Photodynamic Therapy , 2013, Materials.
[267] Michael R Hamblin,et al. Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. , 1997, British Journal of Cancer.
[268] Michael R Hamblin,et al. Combination approaches to potentiate immune response after photodynamic therapy for cancer , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[269] P. McCarron,et al. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. , 2008, Expert opinion on drug delivery.
[270] R. Kiss,et al. A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT , 2016, Oncogene.
[271] M. Wallace,et al. Comparison of endoscopic treatment modalities for Barrett's neoplasia. , 2015, Gastrointestinal endoscopy.
[272] Michael R Hamblin,et al. Can nanotechnology potentiate photodynamic therapy? , 2012, Nanotechnology reviews.
[273] E J BALDES,et al. The use of a derivative of hematoporhyrin in tumor detection. , 1961, Journal of the National Cancer Institute.
[274] Barbara W. Henderson,et al. Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.
[275] Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation. , 2015, Journal of oral and maxillofacial surgery, medicine, and pathology.
[276] I. Tan,et al. Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy. , 2015, Photodiagnosis and photodynamic therapy.
[277] Jarod C Finlay,et al. A robotic multi-channel platform for interstitial photodynamic therapy , 2013, Photonics West - Biomedical Optics.
[278] R. Dummer,et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up. , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[279] Ling Yang,et al. Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer. , 2015, Acta biomaterialia.
[280] C. Mosse,et al. A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus , 2013, Lasers in Medical Science.
[281] H. Schild,et al. Heat shock proteins as ligands of toll-like receptors. , 2002, Current topics in microbiology and immunology.
[282] Michael R Hamblin,et al. Stimulation of anti-tumor immunity by photodynamic therapy , 2011, Expert review of clinical immunology.
[283] Michele M. Kim,et al. PDT dose dosimeter for pleural photodynamic therapy , 2016, SPIE BiOS.
[284] Q. Peng,et al. Effects of Photodynamic Therapy on Tumor Stroma , 2004, Ultrastructural pathology.
[285] Tomonori Yano,et al. Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer , 2012, Radiation oncology.
[286] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[287] B. Henderson,et al. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy. , 1992, The Journal of surgical research.
[288] C. Büning,et al. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma , 2016, Gut and liver.
[289] Paola Taroni,et al. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.
[290] A. Lohse,et al. Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study , 2015, Hepatology.
[291] M. Korbelik. Cancer vaccines generated by photodynamic therapy , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[292] Jianlin Shi,et al. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors. , 2015, Angewandte Chemie.
[293] Kenneth K Wang,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.
[294] J. Paoli,et al. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non‐melanoma skin cancers , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[295] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[296] T. Wilt,et al. Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer , 2008, Annals of Internal Medicine.
[297] K. Moghissi,et al. A Surgical View of Photodynamic Therapy in Oncology: A Review , 2015, The Surgery Journal.
[298] K. Szaciłowski,et al. Bioinorganic photochemistry: frontiers and mechanisms. , 2005, Chemical reviews.
[299] P. Krammer,et al. Immune escape of tumors: apoptosis resistance and tumor counterattack , 2002, Journal of leukocyte biology.
[300] Maximilien Vermandel,et al. Comparison of three light doses in the photodynamic treatment of actinic keratosis using mathematical modeling , 2015, Journal of biomedical optics.
[301] Jia-yuan Chen,et al. Successful photodynamic therapy with topical 5-aminolevulinic acid for five cases of cervical intraepithelial neoplasia , 2010, Archives of Gynecology and Obstetrics.
[302] N. Altorki,et al. Outcomes in the management of esophageal cancer , 2014, Journal of surgical oncology.
[303] T. Wieman,et al. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD) , 1999, British Journal of Cancer.
[304] Barbara W. Henderson,et al. Photodynamic therapy with 3‐(1′‐hexyloxyethyl) pyropheophorbide‐a for early‐stage cancer of the larynx: Phase Ib study , 2015, Head & neck.
[305] M. Korbelik,et al. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.
[306] Brian W. Pogue,et al. Estimation of Oxygen Distribution in RIF-1 Tumors by Diffusion Model-Based Interpretation of Pimonidazole Hypoxia and Eppendorf Measurements , 2001, Radiation research.
[307] H. Kato,et al. Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis , 2015, International journal of molecular sciences.
[308] Andrej Wagner,et al. Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin , 2013, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[309] Timothy C Zhu,et al. A review of in‐vivo optical properties of human tissues and its impact on PDT , 2011, Journal of biophotonics.
[310] D. Kessel,et al. Initiation of apoptosis and autophagy by photodynamic therapy , 2006, Lasers in surgery and medicine.
[311] M. Baptista,et al. Photodynamic Efficiency: From Molecular Photochemistry to Cell Death , 2015, International journal of molecular sciences.
[312] G. V. van Dongen,et al. Photosensitizer-antibody conjugates for detection and therapy of cancer. , 2004, Advanced drug delivery reviews.
[313] T Theodossy,et al. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer , 2004, British Journal of Cancer.
[314] Peng Huang,et al. Targeting cancer cell mitochondria as a therapeutic approach. , 2013, Future medicinal chemistry.
[315] J. Becker,et al. Anti-cancer therapies targeting the tumor stroma , 2007, Cancer Immunology, Immunotherapy.
[316] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[317] A. Toren,et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy , 1999, British Journal of Cancer.
[318] C. Wilson,et al. Photodynamic therapy of malignant tumours. , 1972, Lancet.
[319] J. Levy,et al. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.
[320] Stanley B. Brown,et al. Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.
[321] Ronald Sroka,et al. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL). , 2013, Urologic oncology.
[322] G. Paolino,et al. Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons. , 2015, Journal of drugs in dermatology : JDD.
[323] Da Xing,et al. Mechanism of mitochondrial membrane permeabilization during apoptosis under photofrin-mediated photodynamic therapy. , 2012, Journal of X-ray science and technology.
[324] K. Berg,et al. THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.
[325] Tayyaba Hasan,et al. Development and applications of photo-triggered theranostic agents. , 2010, Advanced drug delivery reviews.
[326] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.
[327] L. Stuhr,et al. Hyperbaric oxygen therapy and cancer—a review , 2012, Targeted Oncology.
[328] Michele T. Cooper,et al. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus , 2011, Lasers in surgery and medicine.
[329] Paul M. Ripley,et al. Photodynamic therapy for cancer of the pancreas , 2002, Gut.
[330] Kevin M. Smith,et al. Effect of overall charge and charge distribution on cellular uptake, distribution and phototoxicity of cationic porphyrins in HEp2 cells. , 2010, Journal of photochemistry and photobiology. B, Biology.
[331] D. Kessel,et al. Initiation of Apoptosis versus Necrosis by Photodynamic Therapy with Chloroaluminum Phthalocyanine , 1997, Photochemistry and photobiology.
[332] Michael R Hamblin,et al. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen , 2013, British Journal of Cancer.
[333] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[334] Timothy C. Zhu,et al. PDT dose dosimetry for pleural photodynamic therapy , 2013, Photonics West - Biomedical Optics.
[335] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[336] Michael S Patterson,et al. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro , 2005, Physics in medicine and biology.
[337] Liquid Biopsies. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[338] Colin Hopper,et al. mTHPC-mediated Photodynamic Therapy of Early Stage Oral Squamous Cell Carcinoma: A Comparison to Surgical Treatment , 2013, Annals of Surgical Oncology.
[339] H. S. de Bruijn,et al. Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. , 1999, Cancer research.
[340] Claudio H. Sibata,et al. Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.
[341] T. Hasan,et al. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. , 1997, Radiation research.
[342] L. Scorrano,et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin‐mediated photodynamic therapy , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[343] Gang Zheng,et al. Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.
[344] Oxygen dependency of photocytotoxicity with haematoporphyrin derivative. , 1984, Photochemistry and photobiology.
[345] A. Oseroff,et al. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.
[346] S. Gollnick,et al. Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease , 2014, Cancer Immunology, Immunotherapy.
[347] L. Milgrom. Towards recombinant antibody-fragment targeted Photodynamic Therapy , 2008, Science progress.
[348] C. A. Thissen,et al. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. , 2006, Journal of drugs in dermatology : JDD.
[349] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[350] Zhuang Liu,et al. Photosensitizer-Conjugated Albumin-Polypyrrole Nanoparticles for Imaging-Guided In Vivo Photodynamic/Photothermal Therapy. , 2015, Small.
[351] C. Berking,et al. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis , 2013, The British journal of dermatology.
[352] A. Enk,et al. Treatment with 5-Aminolaevulinic Acid Methylester Is Less Painful than Treatment with 5-Aminolaevulinic Acid Nanoemulsion in Topical Photodynamic Therapy for Actinic Keratosis , 2011, Dermatology.
[353] L. Burgess,et al. Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage , 2015, Clinical Cancer Research.
[354] J. Feyh,et al. Photodynamic therapy in head and neck surgery. , 1990, Journal of photochemistry and photobiology. B, Biology.
[355] B. Dréno,et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout Europe , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[356] Ronald Sroka,et al. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)). , 2013, Photodiagnosis and photodynamic therapy.
[357] K. Kaneko,et al. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: A phase II study , 2012, International journal of cancer.
[358] T. Nagayasu,et al. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial. , 2012, Anticancer research.
[359] Chang Chang,et al. A fast heterogeneous algorithm for light fluence rate for prostate photodynamic therapy , 2010, BiOS.
[360] M. Mohammadnia-Afrouzi,et al. Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy , 2015, Tumor Biology.
[361] W. Jerjes,et al. Prospective evaluation of 110 patients following ultrasound-guided photodynamic therapy for deep seated pathologies. , 2011, Photodiagnosis and photodynamic therapy.
[362] T J Dougherty,et al. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. , 1975, Journal of the National Cancer Institute.
[363] M. Baptista,et al. Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency. , 2011, Free radical biology & medicine.
[364] Mladen Korbelik,et al. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.
[365] Arjen Amelink,et al. Intrinsic photosensitizer fluorescence measured using multi-diameter single-fiber spectroscopy in vivo , 2014, Journal of biomedical optics.
[366] M. Reed,et al. The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.
[367] Tayyaba Hasan,et al. Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus. , 2008, Journal of biomedical optics.
[368] B. Henderson,et al. A Prospective Study of Pain Control by a 2-Step Irradiance Schedule During Topical Photodynamic Therapy of Nonmelanoma Skin Cancer , 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[369] D. B. Seeley,et al. Ultraviolet Radiation , 1952, The Yale Journal of Biology and Medicine.
[370] D. Kessel,et al. Effects of the Oxygenation Level on Formation of Different Reactive Oxygen Species During Photodynamic Therapy , 2013, Photochemistry and photobiology.
[371] H. Moseley,et al. Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.
[372] Francisco Sanz-Rodríguez,et al. Photodynamic therapy of cancer. Basic principles and applications , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[373] Yong‐Chul Kim,et al. Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy. , 2015, Bioorganic & medicinal chemistry.
[374] I. Tan,et al. The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses. , 2015, Photodiagnosis and photodynamic therapy.
[375] H. S. de Bruijn,et al. EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[376] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[377] Patrizia Agostinis,et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. , 2010, Biochimica et biophysica acta.
[378] P. van Erp,et al. Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy , 2008, Dermatology.
[379] E. Snellman,et al. Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion (BF‐200) with methyl‐5‐aminolaevulinate , 2014, The British journal of dermatology.
[380] Michael R Hamblin,et al. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[381] J. Ring,et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. , 2006, Journal of drugs in dermatology : JDD.
[382] L. Lilge,et al. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.
[383] T. Nagayasu,et al. How to access photodynamic therapy for bile duct carcinoma. , 2014, Annals of translational medicine.
[384] Thomas Pongratz,et al. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[385] B. Stewart,et al. World Cancer Report , 2003 .
[386] A. Goetz,et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. , 2000, Journal of hepatology.
[387] M. Falasca,et al. Pancreatic cancer: Current research and future directions. , 2016, Biochimica et biophysica acta.
[388] C. Evans,et al. In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform. , 2012, Molecular pharmaceutics.
[389] T. Hasan,et al. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites. , 2006, Chemistry & biology.
[390] G. Puppels,et al. Towards oncological application of Raman spectroscopy , 2009, Journal of biophotonics.